Holding(s) in Company

For filings with the FSA include the annex For filings with issuer exclude the annex TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:ii Finsbury World Wide Pharmaceutical Trust 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments An event changing the breakdown of voting rights Other (please specify): Increase in Total Voting Rights following final conversion X of warrants 3. Full name of person(s) subject to the Rensburg Sheppards Investment Management Limited notification obligation:iii 4. Full name of shareholder(s) N/A (if different from 3.):iv 5. Date of the transaction and date on 5th August 2009 which the threshold is crossed or reached: v 6. Date on which issuer notified: 7th August 2009 7. Threshold(s) that is/are crossed or 5% reached: vi, vii 8. Notified details: A: Voting rights attached to shares viii, ix Class/type of Situation previous Resulting situation after the triggering transaction shares to the triggering transaction if possible Number Number Number Number of voting % of voting rights x using of of of shares rights the ISIN CODE Shares Voting Rights Direct Direct xi Indirect Direct Indirect xii Ordinary Shares 2,910,927 2,910,927 2,871,131 5.84% GB0003385308 B: Qualifying Financial Instruments Resulting situation after the triggering transaction Type of financial Expiration Exercise/ Number of voting % of voting instrument date xiii Conversion Period xiv rights that may be rights acquired if the instrument is exercised/ converted. C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi Resulting situation after the triggering transaction Type of financial Exercise Expiration Exercise/ Number of voting rights % of voting rights instrument price date xvii Conversion instrument refers to xix, xx period xviii Nominal Delta Total (A+B+C) Number of voting rights Percentage of voting rights 2,871,131 5.84% 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi Client holdings registered in the name of Nominee companies 100% owned by Rensburg Sheppards Investment Management Limited. Proxy Voting: 10. Name of the proxy holder: N/A 11. Number of voting rights proxy holder will cease to hold: N/A 12. Date on which proxy holder will cease to hold voting rights: N/A 13. Additional information: N/A 14. Contact name: N/A 15. Contact telephone number: N/A Note: Annex should only be submitted to the FSA not the issuer Annex: Notification of major interests in sharesxxii A: Identity of the persons or legal entity subject to the notification obligation Full name Rensburg Sheppards Investment Management Limited (including legal form of legal entities) Contact address Quayside House (registered office for legal entities) Canal Wharf Leeds LS11 5PU Phone number & email 0113 236 4171 mike.rigby@rsim.co.uk Other useful information Mike Rigby (at least legal representative for legal (Head of Compliance) persons) B: Identity of the notifier, if applicable Full name Philip Martin Beardwell Contact address 2 Gresham Street London EC2V 7QN Phone number & email 020 7597 1356 phil.beardwell@rsim.co.uk Other useful information Senior Compliance Manager (e.g. functional relationship with the person or legal entity subject to the notification obligation) C: Additional information For notes on how to complete form TR-1 please see the FSA website.
UK 100